![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » FDA Approves Actemra for Hospitalized Adults with COVID-19
FDA Approves Actemra for Hospitalized Adults with COVID-19
The FDA has approved Roche’s Actemra (tocilizumab) for intravenous treatment of hospitalized adults who have COVID-19 and are receiving systemic corticosteroids and require supplemental oxygen, non-invasive or invasive mechanical ventilation or extracorporeal membrane oxygenation.
A single 60-minute intravenous infusion monoclonal antibody treatment, Actemra was granted Emergency Use Authorization (EUA) in June 2021 to treat hospitalized adults and children two years and older who have COVID-19.
The agency approval was based on positive results from two clinical trials, but the EUA is still in place for patients under 18 years old.
Upcoming Events
-
18Jul
-
21Oct